Abstract:BACKGROUND: It is of great importance in improving the clinical effect of human islet allograft to study and design models of such large animals as pigs or primates preclinically.OBJECTIVE: To evaluate the effect of different doses of streptozotocin (STZ) on inducing diabetes type Ⅰ models of nonhuman primates.DESIGN, TIME AND SETTING: A contrast observational animal experiment was performed in the Cell Transplantation and Gene Therapy Center, the Third Xiangya Hospital of Central South University from October 2007 to December 2008. MATERIALS: A total of 21 adult male rhesus monkeys were divided into a 125 mg/kg STZ group (n =5), a 75 mg/kg STZ group (n=5) and a 50 mg/kg STZ group (n=11).METHODS: STZ weighed with regard to body mass of animals was prepared into 25 g/L STZ solution with buffer that was prepared in advance. After being filtered and degermed, the new-prepared STZ of 125 mg/kg, 75 mg/kg and 50 mg/kg were administered by intravenous injection into the experimental monkeys respectively, which took 1-5 minutes.MAIN OUTCOME MEASURES: Liver and renal function, glucose metabolism and histomorphological changes of animals during 1-16 weeks following administration.RESULTS: In 125 mg/kg STZ group, two rhesus monkeys died, in 8 hours following STZ administration, of serious hypoglycemia caused by severely damaged pancreas β cells; All rhesus monkeys in this group had got significantly increased liver transaminase, serum creatinine and urea nitrogen at week 1 following STZ administration, which reached a peak during 2-4 weeks; One rhesus monkey in this group showed severe shortage of endogenous trypsin and hyperglycemia irreversible by exogenous insulin following STZ administration, and finally died at day 13 following STZ administration due to the glucose metabolic disorder, ketoacidosis, liver and renal failure; The other two survivors in this group kept high level of liver transaminase,urea nitrogen and serum creatinine throughout the observation period. In 75 mg/kg STZ group, rhesus monkeys presented significantly increased liver transaminase, serum creatinine and urea nitrogen at week 1-2 following STZ administration; After 4 weeks following administration, their liver and renal function presented with abnormality of different degrees; One rhesus monkey in this group had got injured renal function, decreased power of resistance, eyelid edema, general dropsy and irreversible infected rump after injection of STZ, and finally died at the end of week 5 following administration; Another rhesus in this group presented with irreversible continuous hyperglycemia, inappetence and significantly decreased weight, and finally died ofsystemic failure at week 9 following administration. In the 50 mg/kg STZ group, renal function of monkeys were slightly affected, with a transient mild rise which return to the normal level by the end of week 4 following administration; Only 3 animals in this group appeared eyelid edema during 1-4 weeks following administration which disappeared afterwards.CONCLUSION: STZ of 50 mg/kg is possibly the optimal dose for inducing diabetes models in most rhesus monkeys.

Optimized alloxan-induced diabetic rabbit model

Administration of Insulin to the Rabbit Model with Diabetes Mellitus Induced by Alloxan and the Formatin of Diabetic Nephropathy

Effect of Dexamethasone Pretreatment on Alloxan Induced Diabetic Rabbit Model

STUDY ON THE DIABETIC RATS MODEL ESTABLISHMENT BY THE ALLOXAN MULTIPLE ADMINISTRATION

Influence factors of different doses of Alloxan on diabetic mice model

Study on the Diabetic Model Induced by Streptozocin in Wistar Rats

Diabetic Model Induced by Alloxan in Mice and Its Affecting Factors

Comparison Between the Effects of Alloxan and Streptozotoci on Inducing Diabetes in Mice

Hemolytic effect of puerarin injection on normal and diabetic rabbits

Establishment of Diabetes Rat Model of Kidney Yin Deficiency

Influences on Serum Insulin and Glucose by Different Fasting Time in Alloxan Diabetic Mice

Influence of Streptozocin's Dose on Inductive Effect of Diabetes in C57BL/6J Mice

The effects of dosage and the routes of administrations of streptozotocin and alloxan on induction rate of type1 diabetes mellitus and mortality rate in rats

Establishment of Diabetic Rats Models with Erectile Dysfunction

Study on the Optimization and Stability of Single-dose Streptozotocin-induced Diabetic Modelling in Rats

Exploration of the Establishment Methods of Rat Models of Diabetes Mellitus Induced by Streptozotocin Combined with High Fat Diet

Establishment of Rabbit Models of Diabetic and Non-Diabetic Atherosclerosis

Establishment of Diabetes Ⅱ Animal Model and Study on Indexes Related to Diabetic Complication

Primate models of diabetes induced by streptozotocin

The Serum Glucose/lipid Effect Extraction from Red Deer Pilose Antler on Diabetic ICR Mice Induced by Alloxan

Optimization and Evaluation of Type 2 Diabetes Induced by High-Fat Diet and Low Dose of STZ in C57BL/6J Mouse Model